The PPARA/RXR and FXR and PXR/RXR activation pathways were also identified in BPS-treated preadipocytes and they have all been shown to modulate adipogenesis, lipid metabolism or obesity [42, 49–52]. This evidence concerns the gene NR1I2 and obesity due to melanocortin 4 receptor deficiency.